AMPHASTAR PHARMACEUTICALS IN (AMPH)
US03209R1032 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 437.8M 25.16% | 499M 13.98% | 644.395M 29.14% | 752.41M 16.76% | 822.71M 9.34% | 890.73M 8.27% | 990.93M 11.25% | 975.12M -1.60% | 1.025B 5.12% | 1.057B 3.12% | 1.081B 2.27% | |
| EBITDA YoY % growth | 93.39M 187.09% | 132.74M 42.14% | 237.722M 79.09% | 305.18M 28.38% | 341.95M 12.05% | 391.07M 14.36% | 534.28M 36.62% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 69.9M 535.45% | 107.5M 53.79% | 199.687M 85.76% | 268.78M 34.60% | 302.7M 12.62% | 337.94M 11.64% | 405.14M 19.89% | 325.38M -19.69% | 343.74M 5.64% | 357M 3.86% | 368.22M 3.14% | |
| Operating Margin | 15.97% | 21.54% | 30.99% | 35.72% | 36.79% | 37.94% | 40.88% | 33.37% | 33.54% | 33.77% | 34.06% | |
| EPS YoY % growth | 1.36 112.50% | 1.97 44.85% | 3.30 67.51% | 3.97 20.24% | 4.33 9.11% | 4.90 13.13% | 5.90 20.48% | 4.53 -23.25% | 4.65 2.70% | 4.70 1.10% | 4.70 |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.99 11.97% | 0.98 -5.70% | 1.03 9.49% | 1.15 19.96% | 1.21 23.03% |
| Revenue Q2Q % growth | 196.55M 10.36% | 192.09M 11.79% | 199.89M 9.59% | 213.03M 11.41% | 223.41M 13.67% |
| EBITDA Q2Q % growth | 82.266M -10.60% | 86.292M 41.48% | 86.496M 6.33% | 94.962M -1.67% | 89.556M 8.86% |
| EBIT Q2Q % growth | 67.166M 24.43% | 65.484M 36.40% | 71.91M 30.23% | 79.968M 40.18% | 93.738M 39.56% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.96 -16.52% | 1.01 | -0.05 | -4.74% |
| Q2 2024 Q2Q % growth | 0.94 44.62% | 0.79 | 0.15 | 19.17% |
| Q1 2024 Q2Q % growth | 1.04 67.74% | 0.98 | 0.06 | 6.52% |
| Q4 2023 Q2Q % growth | 0.88 20.55% | 0.94 | -0.06 | -6.79% |
| Q3 2023 Q2Q % growth | 1.15 202.63% | 0.71 | 0.44 | 62.28% |
| Q2 2023 Q2Q % growth | 0.65 66.67% | 0.57 | 0.08 | 13.74% |
| Q1 2023 Q2Q % growth | 0.62 31.91% | 0.48 | 0.14 | 27.86% |
| Q4 2022 Q2Q % growth | 0.73 73.81% | 0.41 | 0.32 | 76.19% |
| Q3 2022 Q2Q % growth | 0.38 -17.39% | 0.40 | -0.02 | -5.52% |
| Q2 2022 Q2Q % growth | 0.39 85.71% | 0.35 | 0.04 | 9.87% |
| Q1 2022 Q2Q % growth | 0.47 74.07% | 0.37 | 0.10 | 28.00% |
| Q4 2021 Q2Q % growth | 0.42 162.50% | 0.37 | 0.05 | 13.85% |
| Q3 2021 Q2Q % growth | 0.46 206.67% | 0.25 | 0.21 | 85.34% |
| Q2 2021 Q2Q % growth | 0.21 31.25% | 0.21 | 0.00 | -1.17% |
| Q1 2021 Q2Q % growth | 0.27 58.82% | 0.19 | 0.08 | 43.64% |
| Q4 2020 Q2Q % growth | 0.16 128.57% | 0.14 | 0.02 | 14.38% |
| Q3 2020 Q2Q % growth | 0.15 50.00% | 0.14 | 0.01 | 4.72% |
| Q2 2020 Q2Q % growth | 0.16 100.00% | 0.14 | 0.02 | 15.59% |
| Q1 2020 Q2Q % growth | 0.17 70.00% | 0.09 | 0.08 | 93.80% |
| Q4 2019 Q2Q % growth | 0.07 -46.15% | 0.08 | -0.01 | -7.47% |
| Q3 2019 Q2Q % growth | 0.10 -16.67% | 0.07 | 0.03 | 46.70% |
| Q2 2019 Q2Q % growth | 0.08 166.67% | 0.03 | 0.05 | 129.53% |
| Q1 2019 Q2Q % growth | 0.10 300.00% | 0.04 | 0.06 | 145.10% |
| Q4 2018 Q2Q % growth | 0.13 | 0.11 | 0.02 | 15.86% |
| Q3 2018 Q2Q % growth | 0.12 | 0.11 | 0.01 | 6.95% |
| Q2 2018 Q2Q % growth | 0.03 | 0.07 | -0.04 | -56.96% |
| Q1 2018 Q2Q % growth | -0.05 | 0.08 | -0.13 | -165.36% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 191.214M 5.90% | 198.59M | -7.376M | -3.71% |
| Q2 2024 Q2Q % growth | 182.394M 25.17% | 174.36M | 8.034M | 4.61% |
| Q1 2024 Q2Q % growth | 171.836M 22.72% | 177.51M | -5.674M | -3.20% |
| Q4 2023 Q2Q % growth | 178.105M 31.93% | 179M | -895K | -0.50% |
| Q3 2023 Q2Q % growth | 180.556M 50.34% | 178.12M | 2.436M | 1.37% |
| Q2 2023 Q2Q % growth | 145.712M 17.99% | 140.12M | 5.592M | 3.99% |
| Q1 2023 Q2Q % growth | 140.022M 16.30% | 136.85M | 3.172M | 2.32% |
| Q4 2022 Q2Q % growth | 135M 11.66% | 129.52M | 5.48M | 4.23% |
| Q3 2022 Q2Q % growth | 120.1M 7.04% | 128.9M | -8.8M | -6.83% |
| Q2 2022 Q2Q % growth | 123.5M 21.44% | 120.42M | 3.08M | 2.56% |
| Q1 2022 Q2Q % growth | 120.4M 16.89% | 115.97M | 4.43M | 3.82% |
| Q4 2021 Q2Q % growth | 120.9M 26.07% | 113.87M | 7.03M | 6.17% |
| Q3 2021 Q2Q % growth | 112.2M 34.53% | 105.31M | 6.89M | 6.54% |
| Q2 2021 Q2Q % growth | 101.7M 18.53% | 103.41M | -1.71M | -1.65% |
| Q1 2021 Q2Q % growth | 103M 21.61% | 99.207M | 3.793M | 3.82% |
| Q4 2020 Q2Q % growth | 95.9M 14.99% | 90.717M | 5.183M | 5.71% |
| Q3 2020 Q2Q % growth | 83.4M 4.12% | 93.088M | -9.688M | -10.41% |
| Q2 2020 Q2Q % growth | 85.8M 8.61% | 88.348M | -2.548M | -2.88% |
| Q1 2020 Q2Q % growth | 84.7M 6.14% | 84.631M | 69K | 0.08% |
| Q4 2019 Q2Q % growth | 83.4M -7.02% | 83.425M | -25K | -0.03% |
| Q3 2019 Q2Q % growth | 80.1M 6.09% | 80.104M | -4K | 0.00% |
| Q2 2019 Q2Q % growth | 79M 11.27% | 79.166M | -166K | -0.21% |
| Q1 2019 Q2Q % growth | 79.8M 36.64% | 77.724M | 2.076M | 2.67% |
| Q4 2018 Q2Q % growth | 89.7M | 79.747M | 9.953M | 12.48% |
| Q3 2018 Q2Q % growth | 75.5M | 76.225M | -725K | -0.95% |
| Q2 2018 Q2Q % growth | 71M | 64.158M | 6.842M | 10.66% |
| Q1 2018 Q2Q % growth | 58.4M | 61.965M | -3.565M | -5.75% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.7% | -1.87% | -1.99% |
| Revenue | 0% | -6.49% | -0.4% | -1.08% |